Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypogonadism | 28 | 2022 | 802 | 2.550 |
Why?
|
Testosterone | 29 | 2022 | 2495 | 1.760 |
Why?
|
Gonadotropin-Releasing Hormone | 22 | 2019 | 1142 | 1.410 |
Why?
|
Luteinizing Hormone | 18 | 2019 | 828 | 1.000 |
Why?
|
Follicle Stimulating Hormone | 12 | 2010 | 731 | 1.000 |
Why?
|
Turner Syndrome | 5 | 2021 | 129 | 0.720 |
Why?
|
Gonadotropins | 8 | 2010 | 241 | 0.670 |
Why?
|
Klinefelter Syndrome | 1 | 2019 | 48 | 0.650 |
Why?
|
Hormone Replacement Therapy | 7 | 2022 | 751 | 0.620 |
Why?
|
Neurosecretory Systems | 6 | 2019 | 223 | 0.590 |
Why?
|
Inhibins | 8 | 2013 | 210 | 0.520 |
Why?
|
Receptors, LHRH | 8 | 2009 | 158 | 0.500 |
Why?
|
Gonadal Steroid Hormones | 6 | 2010 | 706 | 0.490 |
Why?
|
Performance-Enhancing Substances | 1 | 2014 | 31 | 0.460 |
Why?
|
Androgens | 6 | 2019 | 1279 | 0.450 |
Why?
|
Hypothalamus | 4 | 2010 | 1003 | 0.410 |
Why?
|
Spermatogenesis | 2 | 2012 | 259 | 0.380 |
Why?
|
Estradiol | 8 | 2010 | 1947 | 0.380 |
Why?
|
Pituitary Gland | 3 | 2010 | 635 | 0.340 |
Why?
|
Polycystic Ovary Syndrome | 5 | 2015 | 391 | 0.340 |
Why?
|
Kallmann Syndrome | 10 | 2010 | 142 | 0.340 |
Why?
|
Hyperthyroidism | 1 | 2012 | 292 | 0.340 |
Why?
|
Sex Hormone-Binding Globulin | 5 | 2022 | 557 | 0.300 |
Why?
|
Iodine Radioisotopes | 1 | 2012 | 1030 | 0.300 |
Why?
|
DNA Nucleotidyltransferases | 2 | 1999 | 177 | 0.300 |
Why?
|
Insulin Resistance | 4 | 2019 | 3989 | 0.290 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 7 | 2009 | 259 | 0.260 |
Why?
|
Integrases | 2 | 1999 | 520 | 0.260 |
Why?
|
Leydig Cells | 1 | 2005 | 55 | 0.240 |
Why?
|
Menstrual Cycle | 2 | 2008 | 539 | 0.240 |
Why?
|
Hormone Antagonists | 3 | 2001 | 109 | 0.240 |
Why?
|
Reproduction | 3 | 2013 | 645 | 0.230 |
Why?
|
Androgen-Insensitivity Syndrome | 1 | 2004 | 33 | 0.230 |
Why?
|
Aromatase Inhibitors | 3 | 2007 | 519 | 0.220 |
Why?
|
Oxidative Phosphorylation | 1 | 2005 | 502 | 0.210 |
Why?
|
Human Growth Hormone | 2 | 1999 | 640 | 0.210 |
Why?
|
Testis | 6 | 2013 | 784 | 0.200 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2007 | 627 | 0.200 |
Why?
|
Eunuchism | 1 | 2001 | 19 | 0.190 |
Why?
|
Karyotyping | 2 | 2021 | 1176 | 0.180 |
Why?
|
Glucose | 1 | 2013 | 4339 | 0.180 |
Why?
|
46, XX Disorders of Sex Development | 1 | 2021 | 34 | 0.180 |
Why?
|
Dipeptides | 2 | 2000 | 386 | 0.170 |
Why?
|
Ketoconazole | 3 | 2007 | 95 | 0.170 |
Why?
|
Survivors | 1 | 2010 | 2379 | 0.160 |
Why?
|
Glycoprotein Hormones, alpha Subunit | 1 | 1999 | 95 | 0.160 |
Why?
|
Prostatic Neoplasms | 1 | 2022 | 11094 | 0.160 |
Why?
|
DNA Topoisomerases, Type I | 1 | 1999 | 108 | 0.160 |
Why?
|
Oxygen Consumption | 1 | 2005 | 1870 | 0.160 |
Why?
|
Eukaryotic Cells | 1 | 1999 | 191 | 0.150 |
Why?
|
Substance-Related Disorders | 1 | 2014 | 4418 | 0.150 |
Why?
|
Male | 53 | 2022 | 363975 | 0.150 |
Why?
|
Extracellular Matrix Proteins | 5 | 2012 | 833 | 0.150 |
Why?
|
Diabetes Complications | 2 | 1995 | 1317 | 0.140 |
Why?
|
Adult | 44 | 2022 | 223253 | 0.140 |
Why?
|
Receptors, Androgen | 1 | 2004 | 1089 | 0.140 |
Why?
|
Blood Chemical Analysis | 2 | 2018 | 434 | 0.140 |
Why?
|
Virilism | 1 | 1997 | 28 | 0.140 |
Why?
|
Mosaicism | 1 | 2021 | 481 | 0.140 |
Why?
|
Homozygote | 2 | 2001 | 1774 | 0.140 |
Why?
|
Hypopituitarism | 1 | 1999 | 253 | 0.140 |
Why?
|
Humans | 75 | 2022 | 766432 | 0.140 |
Why?
|
Growth Hormone | 1 | 1999 | 572 | 0.130 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2019 | 12236 | 0.130 |
Why?
|
Stress, Physiological | 1 | 2004 | 1404 | 0.130 |
Why?
|
Fertility | 1 | 2001 | 770 | 0.130 |
Why?
|
Periodicity | 1 | 1998 | 347 | 0.130 |
Why?
|
Genes, BRCA1 | 1 | 2000 | 753 | 0.130 |
Why?
|
Ovarian Cysts | 1 | 1997 | 107 | 0.130 |
Why?
|
Mutagenesis | 1 | 2000 | 1228 | 0.130 |
Why?
|
Goiter | 1 | 1996 | 86 | 0.130 |
Why?
|
Thyrotoxicosis | 1 | 1996 | 85 | 0.120 |
Why?
|
Renin-Angiotensin System | 2 | 1997 | 735 | 0.120 |
Why?
|
Valproic Acid | 2 | 2008 | 444 | 0.120 |
Why?
|
Pituitary Diseases | 1 | 1996 | 137 | 0.120 |
Why?
|
Cystic Fibrosis | 2 | 1995 | 1284 | 0.120 |
Why?
|
Migraine Disorders | 1 | 2008 | 1710 | 0.120 |
Why?
|
Aldosterone | 2 | 1997 | 881 | 0.120 |
Why?
|
Pedigree | 11 | 2010 | 4537 | 0.120 |
Why?
|
Insulin | 2 | 2010 | 6608 | 0.120 |
Why?
|
Mutagenesis, Insertional | 1 | 1997 | 663 | 0.120 |
Why?
|
Orchiectomy | 2 | 2010 | 465 | 0.110 |
Why?
|
Phenotype | 11 | 2021 | 16721 | 0.110 |
Why?
|
Oligopeptides | 2 | 2010 | 1195 | 0.110 |
Why?
|
Transcriptional Activation | 1 | 2000 | 1749 | 0.110 |
Why?
|
Blood Glucose | 3 | 2010 | 6422 | 0.110 |
Why?
|
Follicle Stimulating Hormone, Human | 1 | 2013 | 25 | 0.110 |
Why?
|
Estrogens | 1 | 2000 | 1528 | 0.110 |
Why?
|
Oxygen | 1 | 2005 | 4251 | 0.110 |
Why?
|
Abdominal Muscles | 1 | 1994 | 172 | 0.110 |
Why?
|
Hyperprolactinemia | 2 | 2008 | 123 | 0.110 |
Why?
|
Mutation | 15 | 2012 | 30220 | 0.110 |
Why?
|
BRCA1 Protein | 1 | 2000 | 1155 | 0.110 |
Why?
|
Puberty, Delayed | 4 | 2009 | 124 | 0.110 |
Why?
|
Epilepsy | 2 | 2008 | 3317 | 0.110 |
Why?
|
Enzyme Inhibitors | 2 | 2001 | 3721 | 0.110 |
Why?
|
Renal Dialysis | 1 | 2022 | 1790 | 0.100 |
Why?
|
Feedback | 3 | 2001 | 797 | 0.100 |
Why?
|
Estrogen Replacement Therapy | 1 | 2019 | 1205 | 0.100 |
Why?
|
Edema | 1 | 1997 | 764 | 0.100 |
Why?
|
Postmenopause | 2 | 2003 | 2517 | 0.100 |
Why?
|
Ovary | 1 | 1997 | 963 | 0.100 |
Why?
|
Endocrinology | 1 | 2018 | 441 | 0.100 |
Why?
|
Mitochondria | 1 | 2005 | 3676 | 0.100 |
Why?
|
Body Composition | 4 | 2010 | 2441 | 0.100 |
Why?
|
Receptors, G-Protein-Coupled | 3 | 2008 | 1245 | 0.090 |
Why?
|
Prevalence | 3 | 2019 | 15820 | 0.090 |
Why?
|
Liver Diseases | 1 | 2019 | 1303 | 0.090 |
Why?
|
Odds Ratio | 2 | 2022 | 9654 | 0.090 |
Why?
|
Genetic Counseling | 1 | 2015 | 634 | 0.090 |
Why?
|
Molecular Sequence Data | 8 | 2007 | 17605 | 0.090 |
Why?
|
Diabetic Neuropathies | 1 | 1994 | 409 | 0.090 |
Why?
|
Sexual Maturation | 1 | 2012 | 256 | 0.090 |
Why?
|
Bipolar Disorder | 1 | 2008 | 5130 | 0.090 |
Why?
|
Infertility, Male | 1 | 2013 | 395 | 0.090 |
Why?
|
Seminiferous Tubules | 1 | 2009 | 25 | 0.090 |
Why?
|
Puberty | 3 | 2009 | 495 | 0.090 |
Why?
|
Mutation, Missense | 3 | 2019 | 2590 | 0.080 |
Why?
|
Hypothalamo-Hypophyseal System | 3 | 2010 | 702 | 0.080 |
Why?
|
Infertility, Female | 1 | 2015 | 763 | 0.080 |
Why?
|
Aging | 3 | 2018 | 8725 | 0.080 |
Why?
|
Bacterial Proteins | 2 | 1999 | 3833 | 0.080 |
Why?
|
Feedback, Physiological | 2 | 2008 | 480 | 0.080 |
Why?
|
Seminiferous Epithelium | 1 | 2008 | 9 | 0.080 |
Why?
|
Recombinases | 2 | 1999 | 70 | 0.080 |
Why?
|
Lymphocytes | 1 | 1996 | 2605 | 0.080 |
Why?
|
Hyperandrogenism | 1 | 2008 | 46 | 0.080 |
Why?
|
Conserved Sequence | 3 | 2007 | 1159 | 0.070 |
Why?
|
Middle Aged | 21 | 2022 | 223127 | 0.070 |
Why?
|
Population Surveillance | 1 | 2018 | 2594 | 0.070 |
Why?
|
Gastrointestinal Hormones | 1 | 2008 | 101 | 0.070 |
Why?
|
Ovulation | 1 | 2008 | 181 | 0.070 |
Why?
|
Amino Acid Sequence | 6 | 2007 | 13410 | 0.070 |
Why?
|
Genetic Testing | 1 | 2021 | 3590 | 0.070 |
Why?
|
Olfaction Disorders | 3 | 2006 | 225 | 0.070 |
Why?
|
Nerve Tissue Proteins | 5 | 2012 | 4400 | 0.070 |
Why?
|
Reference Values | 5 | 2015 | 4913 | 0.070 |
Why?
|
Athletes | 1 | 2014 | 1162 | 0.070 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2007 | 355 | 0.070 |
Why?
|
Receptors, Peptide | 1 | 2008 | 280 | 0.070 |
Why?
|
Triazines | 1 | 2008 | 311 | 0.070 |
Why?
|
Aged | 15 | 2022 | 171234 | 0.060 |
Why?
|
Young Adult | 8 | 2022 | 59928 | 0.060 |
Why?
|
Nitriles | 2 | 2001 | 981 | 0.060 |
Why?
|
Partial Pressure | 1 | 2005 | 247 | 0.060 |
Why?
|
Remission, Spontaneous | 2 | 2007 | 384 | 0.060 |
Why?
|
Adipokines | 1 | 2007 | 308 | 0.060 |
Why?
|
Triazoles | 2 | 2001 | 902 | 0.060 |
Why?
|
Glucocorticoids | 3 | 2006 | 2158 | 0.060 |
Why?
|
Glucose Clamp Technique | 1 | 2005 | 262 | 0.060 |
Why?
|
Administration, Oral | 1 | 2013 | 4014 | 0.060 |
Why?
|
Carcinoma | 1 | 1996 | 2323 | 0.060 |
Why?
|
Sperm Count | 3 | 2013 | 227 | 0.060 |
Why?
|
Amenorrhea | 1 | 2008 | 470 | 0.060 |
Why?
|
Adolescent | 14 | 2019 | 88898 | 0.060 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2004 | 193 | 0.060 |
Why?
|
Immunoassay | 1 | 2007 | 742 | 0.060 |
Why?
|
Recombination, Genetic | 2 | 1999 | 1525 | 0.050 |
Why?
|
Waist-Hip Ratio | 1 | 2005 | 521 | 0.050 |
Why?
|
Female | 30 | 2021 | 396354 | 0.050 |
Why?
|
Plasmids | 2 | 2000 | 2267 | 0.050 |
Why?
|
Radiotherapy | 1 | 2010 | 1497 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2004 | 11501 | 0.050 |
Why?
|
Neuropeptides | 1 | 2008 | 950 | 0.050 |
Why?
|
Thyroid Neoplasms | 1 | 1996 | 2355 | 0.050 |
Why?
|
Pregnancy Complications | 1 | 1996 | 2971 | 0.050 |
Why?
|
Hyperinsulinism | 1 | 2005 | 402 | 0.050 |
Why?
|
Public Health | 1 | 2014 | 2681 | 0.050 |
Why?
|
Glucose Intolerance | 1 | 2005 | 578 | 0.050 |
Why?
|
Gonadotropins, Pituitary | 1 | 2000 | 70 | 0.040 |
Why?
|
Estrogen Antagonists | 1 | 2001 | 151 | 0.040 |
Why?
|
Bromocriptine | 1 | 2000 | 93 | 0.040 |
Why?
|
DAX-1 Orphan Nuclear Receptor | 3 | 2009 | 29 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2010 | 10740 | 0.040 |
Why?
|
Giant Cell Arteritis | 1 | 2004 | 308 | 0.040 |
Why?
|
Follow-Up Studies | 4 | 2019 | 39283 | 0.040 |
Why?
|
Prednisone | 1 | 2004 | 1566 | 0.040 |
Why?
|
Time Factors | 5 | 2012 | 40116 | 0.040 |
Why?
|
Chorionic Gonadotropin | 1 | 2001 | 458 | 0.040 |
Why?
|
beta-Galactosidase | 1 | 2000 | 573 | 0.040 |
Why?
|
Radiography | 1 | 2010 | 6967 | 0.040 |
Why?
|
Secretory Rate | 1 | 1998 | 82 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2022 | 996 | 0.040 |
Why?
|
Point Mutation | 1 | 2004 | 1591 | 0.040 |
Why?
|
Repressor Proteins | 2 | 2000 | 2977 | 0.040 |
Why?
|
Base Sequence | 4 | 2007 | 12412 | 0.040 |
Why?
|
Genotype | 6 | 2009 | 13034 | 0.040 |
Why?
|
Chromosomes, Human, Y | 1 | 2019 | 163 | 0.040 |
Why?
|
Administration, Cutaneous | 1 | 2000 | 712 | 0.040 |
Why?
|
Diagnostic Techniques, Endocrine | 1 | 2018 | 43 | 0.040 |
Why?
|
Heart Defects, Congenital | 1 | 2015 | 4712 | 0.040 |
Why?
|
Liver Function Tests | 1 | 2019 | 527 | 0.040 |
Why?
|
Pulsatile Flow | 1 | 1999 | 318 | 0.040 |
Why?
|
Body Water | 1 | 1999 | 337 | 0.040 |
Why?
|
Anticonvulsants | 1 | 2008 | 1920 | 0.040 |
Why?
|
Body Mass Index | 2 | 2022 | 13045 | 0.040 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2004 | 1621 | 0.040 |
Why?
|
Binding Sites | 2 | 2004 | 6010 | 0.040 |
Why?
|
Bone and Bones | 1 | 2008 | 2559 | 0.040 |
Why?
|
Models, Molecular | 3 | 2007 | 5385 | 0.030 |
Why?
|
Androstenedione | 1 | 1997 | 138 | 0.030 |
Why?
|
Ligands | 1 | 2004 | 3276 | 0.030 |
Why?
|
Catalytic Domain | 1 | 1999 | 698 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2000 | 1677 | 0.030 |
Why?
|
Leptin | 1 | 2005 | 1596 | 0.030 |
Why?
|
Nifedipine | 1 | 1997 | 220 | 0.030 |
Why?
|
Prospective Studies | 4 | 2008 | 54826 | 0.030 |
Why?
|
Recombinant Proteins | 2 | 2013 | 6507 | 0.030 |
Why?
|
Protein Conformation | 2 | 2006 | 3946 | 0.030 |
Why?
|
Evidence-Based Medicine | 3 | 2018 | 3690 | 0.030 |
Why?
|
Catalysis | 1 | 1997 | 767 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 1998 | 1621 | 0.030 |
Why?
|
Salmonella typhimurium | 1 | 1997 | 348 | 0.030 |
Why?
|
Dogs | 1 | 2000 | 3834 | 0.030 |
Why?
|
Models, Genetic | 2 | 2007 | 3450 | 0.030 |
Why?
|
Sexual Dysfunction, Physiological | 2 | 2010 | 364 | 0.030 |
Why?
|
Immunoblotting | 1 | 1997 | 1646 | 0.030 |
Why?
|
Antipsychotic Agents | 1 | 2008 | 3078 | 0.030 |
Why?
|
Gene Frequency | 3 | 2008 | 3624 | 0.030 |
Why?
|
Glycoproteins | 1 | 2002 | 2201 | 0.030 |
Why?
|
COS Cells | 2 | 2009 | 1135 | 0.030 |
Why?
|
Pulse Therapy, Drug | 1 | 2013 | 37 | 0.030 |
Why?
|
Heterozygote | 3 | 2007 | 2795 | 0.030 |
Why?
|
Hyperplasia | 1 | 1997 | 1150 | 0.030 |
Why?
|
Osteoporosis | 1 | 2003 | 1581 | 0.030 |
Why?
|
Protein Structure, Tertiary | 1 | 2000 | 3757 | 0.030 |
Why?
|
Dexamethasone | 1 | 2001 | 1962 | 0.030 |
Why?
|
Muscle, Skeletal | 2 | 2010 | 4966 | 0.030 |
Why?
|
Drug Resistance | 1 | 1999 | 1591 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2004 | 4779 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2003 | 2645 | 0.030 |
Why?
|
Blotting, Western | 1 | 2000 | 5021 | 0.030 |
Why?
|
Alopecia | 1 | 1997 | 416 | 0.030 |
Why?
|
Gene Deletion | 1 | 2000 | 2668 | 0.030 |
Why?
|
Vasodilator Agents | 1 | 1997 | 988 | 0.030 |
Why?
|
Cytokines | 1 | 2007 | 7436 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 1997 | 3053 | 0.020 |
Why?
|
Adenosine Triphosphatases | 1 | 1996 | 840 | 0.020 |
Why?
|
Risk Factors | 2 | 2010 | 74828 | 0.020 |
Why?
|
Treatment Outcome | 5 | 2012 | 65202 | 0.020 |
Why?
|
Prognosis | 1 | 2012 | 29922 | 0.020 |
Why?
|
Animals | 8 | 2009 | 168887 | 0.020 |
Why?
|
Fetus | 1 | 1998 | 1878 | 0.020 |
Why?
|
Fatal Outcome | 1 | 1996 | 1838 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 1999 | 1935 | 0.020 |
Why?
|
DNA | 3 | 2010 | 7207 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2000 | 6061 | 0.020 |
Why?
|
Carcinoma, Papillary | 1 | 1996 | 791 | 0.020 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 1996 | 1137 | 0.020 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2015 | 503 | 0.020 |
Why?
|
Azoospermia | 1 | 2010 | 28 | 0.020 |
Why?
|
Transcription Factors | 4 | 2019 | 12147 | 0.020 |
Why?
|
Receptors, Retinoic Acid | 2 | 2000 | 229 | 0.020 |
Why?
|
Aequorin | 1 | 2008 | 15 | 0.020 |
Why?
|
DNA Mutational Analysis | 2 | 2008 | 4114 | 0.020 |
Why?
|
Phosphotyrosine | 1 | 2009 | 458 | 0.020 |
Why?
|
Child | 4 | 2019 | 80668 | 0.020 |
Why?
|
Anovulation | 1 | 2008 | 56 | 0.020 |
Why?
|
Protein Binding | 2 | 1997 | 9315 | 0.020 |
Why?
|
Body Weight | 1 | 1999 | 4625 | 0.020 |
Why?
|
Consensus | 1 | 2018 | 3198 | 0.020 |
Why?
|
Estriol | 1 | 2007 | 53 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 1996 | 2900 | 0.020 |
Why?
|
Retrospective Studies | 5 | 2019 | 81588 | 0.020 |
Why?
|
Bone Density | 1 | 2000 | 3491 | 0.020 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2009 | 591 | 0.020 |
Why?
|
Cohort Studies | 5 | 2009 | 41703 | 0.020 |
Why?
|
Adipose Tissue | 1 | 1999 | 3314 | 0.020 |
Why?
|
Fibroblast Growth Factor 8 | 1 | 2007 | 62 | 0.020 |
Why?
|
DNA-Binding Proteins | 3 | 2000 | 9611 | 0.020 |
Why?
|
Remission Induction | 1 | 2013 | 2413 | 0.020 |
Why?
|
Estrone | 1 | 2007 | 234 | 0.020 |
Why?
|
Subcutaneous Fat | 1 | 2010 | 401 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 1998 | 12979 | 0.020 |
Why?
|
Cricetulus | 1 | 2008 | 810 | 0.020 |
Why?
|
Child, Preschool | 2 | 2019 | 42576 | 0.020 |
Why?
|
Pregnancy | 3 | 2015 | 30235 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2013 | 1312 | 0.020 |
Why?
|
Societies, Medical | 1 | 2018 | 3953 | 0.020 |
Why?
|
CHO Cells | 1 | 2008 | 1376 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2021 | 18979 | 0.020 |
Why?
|
Sex Factors | 1 | 1999 | 10614 | 0.010 |
Why?
|
Mental Health | 1 | 2019 | 3270 | 0.010 |
Why?
|
Intra-Abdominal Fat | 1 | 2010 | 624 | 0.010 |
Why?
|
Genetic Heterogeneity | 1 | 2008 | 735 | 0.010 |
Why?
|
Cricetinae | 1 | 2008 | 2416 | 0.010 |
Why?
|
Methods | 1 | 2005 | 1065 | 0.010 |
Why?
|
Organ Size | 1 | 2009 | 2261 | 0.010 |
Why?
|
Inheritance Patterns | 1 | 2006 | 345 | 0.010 |
Why?
|
Escherichia coli | 1 | 1996 | 4211 | 0.010 |
Why?
|
Rats | 1 | 2000 | 23718 | 0.010 |
Why?
|
Syndrome | 1 | 2010 | 3271 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2003 | 6543 | 0.010 |
Why?
|
Menstruation | 1 | 2005 | 310 | 0.010 |
Why?
|
Age of Onset | 1 | 2010 | 3342 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4566 | 0.010 |
Why?
|
Internationality | 1 | 2008 | 1006 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2007 | 2746 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2007 | 1494 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2010 | 1794 | 0.010 |
Why?
|
Cryptorchidism | 1 | 2002 | 152 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2006 | 1742 | 0.010 |
Why?
|
Testicular Hormones | 1 | 2002 | 188 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 2008 | 1791 | 0.010 |
Why?
|
Pituitary-Adrenal System | 1 | 2004 | 553 | 0.010 |
Why?
|
Genetic Variation | 2 | 2006 | 6612 | 0.010 |
Why?
|
Neoplasms | 1 | 2010 | 22343 | 0.010 |
Why?
|
Growth Inhibitors | 1 | 2002 | 375 | 0.010 |
Why?
|
Polymorphism, Genetic | 2 | 2001 | 4249 | 0.010 |
Why?
|
Reference Standards | 1 | 2004 | 1010 | 0.010 |
Why?
|
Cleft Palate | 1 | 2006 | 596 | 0.010 |
Why?
|
Transfection | 1 | 2008 | 5750 | 0.010 |
Why?
|
Recurrence | 1 | 2013 | 8478 | 0.010 |
Why?
|
Proprotein Convertases | 1 | 2000 | 95 | 0.010 |
Why?
|
Family Health | 1 | 2004 | 1253 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 1994 | 3446 | 0.010 |
Why?
|
Mass Screening | 1 | 1995 | 5451 | 0.010 |
Why?
|
Anti-Mullerian Hormone | 1 | 2002 | 420 | 0.010 |
Why?
|
Smell | 1 | 2001 | 259 | 0.010 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2000 | 308 | 0.010 |
Why?
|
Genes, Recessive | 1 | 2001 | 625 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2000 | 20706 | 0.010 |
Why?
|
Operator Regions, Genetic | 1 | 1996 | 33 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 3803 | 0.010 |
Why?
|
Hypertension | 1 | 1997 | 8614 | 0.010 |
Why?
|
DNA Footprinting | 1 | 1996 | 97 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 1995 | 5883 | 0.010 |
Why?
|
Operon | 1 | 1996 | 371 | 0.010 |
Why?
|
Hospitals, Teaching | 1 | 2000 | 1156 | 0.010 |
Why?
|
X Chromosome | 1 | 1998 | 819 | 0.010 |
Why?
|
Renin | 1 | 1997 | 647 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2002 | 4850 | 0.010 |
Why?
|
Biopsy | 1 | 2006 | 6778 | 0.010 |
Why?
|
Genetic Linkage | 1 | 1998 | 2342 | 0.010 |
Why?
|
Delayed-Action Preparations | 1 | 1997 | 966 | 0.010 |
Why?
|
Disease Progression | 1 | 2010 | 13632 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2010 | 10379 | 0.010 |
Why?
|
Mice | 1 | 2000 | 81863 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 59538 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 14643 | 0.010 |
Why?
|
Models, Biological | 1 | 2008 | 9458 | 0.010 |
Why?
|
HIV Infections | 2 | 2010 | 17534 | 0.010 |
Why?
|
Adenosine Triphosphate | 1 | 1996 | 2002 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2000 | 8536 | 0.000 |
Why?
|
Research Design | 1 | 2004 | 6205 | 0.000 |
Why?
|
Neurons | 1 | 2004 | 9515 | 0.000 |
Why?
|
Promoter Regions, Genetic | 1 | 1996 | 5789 | 0.000 |
Why?
|
Blood Pressure | 1 | 1997 | 8532 | 0.000 |
Why?
|
United States | 1 | 2008 | 72910 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2000 | 36562 | 0.000 |
Why?
|